IL-17A/F drugs for Hidradenitis Suppurativa
3 tracked IL-17A/F drugs in the Hidradenitis Suppurativa race. The class explanation lives on the IL-17A/F page; the full indication pipeline across every mechanism is on the Hidradenitis Suppurativa page.
1 approved / phase 41 Phase 31 Phase 2
Head-to-head evidence: bimekizumab vs ORKA-002 · bimekizumab vs sonelokimab